Heart Failure vs Hypertension — Clinical Trial Comparison
Heart Failure
Heart cannot pump blood effectively
VS
Hypertension
Persistently elevated blood pressure
Heart failure and hypertension are closely linked cardiovascular conditions — hypertension is in fact one of the leading causes of heart failure. While they share some treatments (ACE inhibitors, beta blockers), their clinical trial landscapes are quite different. Heart failure trials focus on improving pumping efficiency and survival, while hypertension trials explore better blood pressure control, resistant hypertension, and novel devices.
Key Differences at a Glance
| Feature | Heart Failure | Hypertension |
|---|---|---|
| Primary symptoms | Breathlessness, fluid retention, fatigue, exercise intolerance | Usually asymptomatic; headaches, visual changes in severe cases |
| Common subtypes | HFrEF, HFpEF, HFmrEF, acute, chronic | Essential, resistant, pulmonary, white coat, masked |
| Severity scoring | NYHA Class I-IV, LVEF %, NT-proBNP | Blood pressure reading, ambulatory BP monitoring |
| Link between conditions | ~70% of HF patients have history of hypertension | Uncontrolled hypertension is #1 risk factor for developing HF |
| NICE first-line | ACEi/ARB + beta blocker + SGLT2i + MRA | ACEi/ARB or CCB (step 1), dual therapy (step 2) |
| Prevalence in UK | ~1 million diagnosed | ~12 million adults (1 in 4) |
Clinical Trial Availability
| Trial Aspect | Heart Failure | Hypertension |
|---|---|---|
| UK trials actively recruiting | 60–100 studies | 30–50 studies |
| Most common trial phase | Phase 2–3 | Phase 3–4 |
| Top interventions tested | SGLT2 inhibitors, ARNI, gene therapy, stem cells, cardiac devices | New antihypertensives, device therapy (renal denervation), combination pills, digital monitoring |
| Device trials | ICD, CRT, LVAD, MitraClip | Renal denervation, baroreceptor activation therapy |
| Gene/cell therapy trials | Active (multiple Phase 1–2) | Limited (mostly device-focused) |
| Digital health trials | Remote monitoring, implantable sensors | App-based BP management, home monitoring |
Exciting Emerging Treatments
Heart Failure Trials
- SGLT2 inhibitors — originally for diabetes, now a cornerstone HF treatment
- Gene therapy — delivering SERCA2a and other cardiac genes
- Stem cell therapy — regenerating damaged heart muscle
- Cardiac devices — next-generation ICDs, LVADs, and mitral valve repair
- Cardiac patch technology — engineered tissue for heart repair
- Cardiac myosin activators — directly improving heart contraction
Hypertension Trials
- Renal denervation — catheter-based procedure to reduce nerve activity to kidneys
- Novel mineralocorticoid receptor antagonists — non-steroidal MRAs
- Aldosterone synthase inhibitors — targeting aldosterone production
- Combination single-pill therapies — improving adherence
- Implantable BP sensors — continuous monitoring for resistant HTN
- App-guided titration — AI-assisted medication adjustment
💡 Not sure which trials you qualify for?
Use our Smart Matcher to answer a few questions about your condition and we'll find the most relevant trials for your specific situation — free, instant results.
Eligibility Differences
Heart Failure Trial Criteria
- LVEF measurement required (HFrEF vs HFpEF determines trial eligibility)
- NT-proBNP threshold commonly required for enrolment
- Recent hospitalisation for HF may be required (within 6–12 months)
- Stable optimal medical therapy usually required for 4+ weeks before randomisation
- Device trials may require specific NYHA class and no existing device
Hypertension Trial Criteria
- Documented sustained BP above target despite treatment (for resistant HTN trials)
- Ambulatory BP monitoring may be required to confirm diagnosis
- Most trials exclude secondary hypertension (kidney artery stenosis, endocrine causes)
- Device trials (renal denervation) require confirmed resistant HTN on 3+ drugs
- Medication washout sometimes needed for drug trials
Heart Failure Trials
Find actively recruiting heart failure trials across the UK
Heart Failure TrialsFrequently Asked Questions
Can I join a clinical trial if I have both Heart Failure and Hypertension?
It depends on the specific trial. Many trials allow comorbid conditions as long as the primary condition being studied is clearly dominant. Some trials explicitly exclude patients with significant overlapping conditions. Always check the eligibility criteria carefully and discuss with both the trial team and your specialist.
Which condition has more clinical trials available in the UK?
Hypertension typically has more actively recruiting trials in the UK. However, both conditions have robust research pipelines with new studies opening regularly.
What should I consider when choosing between trials for these conditions?
Consider which condition impacts your quality of life most, what treatments you've already tried, the trial phase (earlier phases are more experimental), the time commitment involved, and whether the trial offers access to treatments not otherwise available. Your specialist can help you prioritise.